Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 30 Oct 2020 for Zentalis Pharmaceuticals, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Recurium Equity, LLC: trading record in brief
Recurium Equity, LLC has a single filing on record, published on 30 October 2020: a transaction in Zentalis Pharmaceuticals, Inc. One trade is not enough to describe a pattern. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Recurium Equity, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 4,147,940 shares0Common StockSEC:0001725160-20-000024:0
1 of 1 declaration